<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455518</url>
  </required_header>
  <id_info>
    <org_study_id>2014-4156</org_study_id>
    <nct_id>NCT02455518</nct_id>
  </id_info>
  <brief_title>Comparative Efficacy of 4 Oral Analgesics</brief_title>
  <official_title>Comparative Efficacy of 4 Oral Analgesics for the Initial Management of Acute Musculoskeletal Extremity Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform a randomized, double blind 4-arm clinical trial of
      the comparative efficacy of 4 oral analgesics in the initial management of acute
      musculoskeletal extremity pain presenting to the ED.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To perform a randomized, double blind 4-arm clinical trial of the comparative efficacy of 4
      oral analgesics in the initial management of acute musculoskeletal extremity pain presenting
      to the ED. The 4 groups are as follows:

        1. Oxycodone/acetaminophen (5/325)

        2. Hydrocodone/acetaminophen (5/325)

        3. Codeine/acetaminophen (30/300)

        4. Ibuprofen/acetaminophen (400/1000)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">October 4, 2017</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores</measure>
    <time_frame>2 hours</time_frame>
    <description>Change in numerical rating scale (NRS) pre and 2 hours post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores</measure>
    <time_frame>1 hour</time_frame>
    <description>Change in numerical rating scale (NRS) pre and 1-hour post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">416</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Oxycodone/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxycodone/acetaminophen (5 mg/325 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrocodone/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydrocodone/acetaminophen (5 mg/300 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Codeine/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Codeine/acetaminophen (30 mg/300 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen/acetaminophen (400 mg/1000 mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone/acetaminophen</intervention_name>
    <arm_group_label>Oxycodone/acetaminophen</arm_group_label>
    <other_name>Percocet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocodone/acetaminophen</intervention_name>
    <arm_group_label>Hydrocodone/acetaminophen</arm_group_label>
    <other_name>Norco</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Codeine/acetaminophen</intervention_name>
    <arm_group_label>Codeine/acetaminophen</arm_group_label>
    <other_name>Tylenol with codeine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen/acetaminophen</intervention_name>
    <arm_group_label>Ibuprofen/acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complaint of acute pain of &lt; 7 days duration

          -  Location of pain in one or more extremities defined as distal to and including the
             shoulder joint in the upper extremities and distal to and including the hip joint in
             the lower extremities;

          -  Radiologic evaluation is planned

        Exclusion Criteria:

          -  Inability to confirm reliable means of phone followup.

          -  Past use of methadone

          -  Chronic condition requiring frequent pain management such as sickle cell disease,
             fibromyalgia, or any neuropathy

          -  History of an adverse reaction to any of the study medications

          -  Opioids taken in the past 24 hours

          -  Ibuprofen or acetaminophen taken in past 8 hours

          -  Pregnancy by either urine or serum HCG testing

          -  Breastfeeding per patient report

          -  History of peptic ulcer disease

          -  Report of any prior use of recreational narcotics

          -  Medical condition that might affect metabolism of opioid analgesics, acetaminophen, or
             ibuprofen such as hepatitis, renal insufficiency, hypo- or hyperthyroidism, Addison's
             or Cushing's disease

          -  Taking any medicine that might interact with one of the study medications, such as
             antidepressant SSRI's or Tricyclics, antipsychotics, anti-malaria medications
             quinidine or halofantrine, Amiodarone or Dronedarone, diphenhydramine, celecoxib,
             ranitidine, cimetidine, ritanovir, terbinafine, or St John's Wort.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <results_first_submitted>December 14, 2017</results_first_submitted>
  <results_first_submitted_qc>February 7, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 13, 2018</results_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Andrew Chang, MD</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Oxycodone/Acetaminophen</title>
          <description>Oxycodone/acetaminophen (5 mg/325 mg)
Oxycodone/acetaminophen</description>
        </group>
        <group group_id="P2">
          <title>Hydrocodone/Acetaminophen</title>
          <description>Hydrocodone/acetaminophen (5 mg/300 mg)
Hydrocodone/acetaminophen</description>
        </group>
        <group group_id="P3">
          <title>Codeine/Acetaminophen</title>
          <description>Codeine/acetaminophen (30 mg/300 mg)
Codeine/acetaminophen</description>
        </group>
        <group group_id="P4">
          <title>Ibuprofen/Acetaminophen</title>
          <description>Ibuprofen/acetaminophen (400 mg/1000 mg)
Ibuprofen/acetaminophen</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="104"/>
                <participants group_id="P3" count="104"/>
                <participants group_id="P4" count="104"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="103"/>
                <participants group_id="P3" count="103"/>
                <participants group_id="P4" count="101"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oxycodone/Acetaminophen</title>
          <description>Oxycodone/acetaminophen (5 mg/325 mg)
Oxycodone/acetaminophen</description>
        </group>
        <group group_id="B2">
          <title>Hydrocodone/Acetaminophen</title>
          <description>Hydrocodone/acetaminophen (5 mg/300 mg)
Hydrocodone/acetaminophen</description>
        </group>
        <group group_id="B3">
          <title>Codeine/Acetaminophen</title>
          <description>Codeine/acetaminophen (30 mg/300 mg)
Codeine/acetaminophen</description>
        </group>
        <group group_id="B4">
          <title>Ibuprofen/Acetaminophen</title>
          <description>Ibuprofen/acetaminophen (400 mg/1000 mg)
Ibuprofen/acetaminophen</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="104"/>
            <count group_id="B2" value="103"/>
            <count group_id="B3" value="103"/>
            <count group_id="B4" value="101"/>
            <count group_id="B5" value="411"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" spread="12"/>
                    <measurement group_id="B2" value="37" spread="13"/>
                    <measurement group_id="B3" value="37" spread="12"/>
                    <measurement group_id="B4" value="37" spread="11"/>
                    <measurement group_id="B5" value="37" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="54"/>
                    <measurement group_id="B5" value="199"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="58"/>
                    <measurement group_id="B4" value="62"/>
                    <measurement group_id="B5" value="247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="34"/>
                    <measurement group_id="B5" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>East Asian/Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="103"/>
                    <measurement group_id="B3" value="103"/>
                    <measurement group_id="B4" value="101"/>
                    <measurement group_id="B5" value="411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores</title>
        <description>Change in numerical rating scale (NRS) pre and 2 hours post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone/Acetaminophen</title>
            <description>Oxycodone/acetaminophen (5 mg/325 mg)
Oxycodone/acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Hydrocodone/Acetaminophen</title>
            <description>Hydrocodone/acetaminophen (5 mg/300 mg)
Hydrocodone/acetaminophen</description>
          </group>
          <group group_id="O3">
            <title>Codeine/Acetaminophen</title>
            <description>Codeine/acetaminophen (30 mg/300 mg)
Codeine/acetaminophen</description>
          </group>
          <group group_id="O4">
            <title>Ibuprofen/Acetaminophen</title>
            <description>Ibuprofen/acetaminophen (400 mg/1000 mg)
Ibuprofen/acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores</title>
          <description>Change in numerical rating scale (NRS) pre and 2 hours post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)</description>
          <units>units on a scale</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="103"/>
                <count group_id="O3" value="103"/>
                <count group_id="O4" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" lower_limit="3.7" upper_limit="5.0"/>
                    <measurement group_id="O2" value="3.5" lower_limit="2.9" upper_limit="4.2"/>
                    <measurement group_id="O3" value="3.9" lower_limit="3.2" upper_limit="4.5"/>
                    <measurement group_id="O4" value="4.3" lower_limit="3.6" upper_limit="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores</title>
        <description>Change in numerical rating scale (NRS) pre and 1-hour post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxycodone/Acetaminophen</title>
            <description>Oxycodone/acetaminophen (5 mg/325 mg)
Oxycodone/acetaminophen</description>
          </group>
          <group group_id="O2">
            <title>Hydrocodone/Acetaminophen</title>
            <description>Hydrocodone/acetaminophen (5 mg/300 mg)
Hydrocodone/acetaminophen</description>
          </group>
          <group group_id="O3">
            <title>Codeine/Acetaminophen</title>
            <description>Codeine/acetaminophen (30 mg/300 mg)
Codeine/acetaminophen</description>
          </group>
          <group group_id="O4">
            <title>Ibuprofen/Acetaminophen</title>
            <description>Ibuprofen/acetaminophen (400 mg/1000 mg)
Ibuprofen/acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores</title>
          <description>Change in numerical rating scale (NRS) pre and 1-hour post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)</description>
          <units>units on a scale</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="103"/>
                <count group_id="O3" value="103"/>
                <count group_id="O4" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" lower_limit="2.6" upper_limit="3.7"/>
                    <measurement group_id="O2" value="2.4" lower_limit="1.8" upper_limit="3.0"/>
                    <measurement group_id="O3" value="2.7" lower_limit="2.1" upper_limit="3.3"/>
                    <measurement group_id="O4" value="2.9" lower_limit="2.4" upper_limit="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were not collected</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Oxycodone/Acetaminophen</title>
          <description>Oxycodone/acetaminophen (5 mg/325 mg)
Oxycodone/acetaminophen</description>
        </group>
        <group group_id="E2">
          <title>Hydrocodone/Acetaminophen</title>
          <description>Hydrocodone/acetaminophen (5 mg/300 mg)
Hydrocodone/acetaminophen</description>
        </group>
        <group group_id="E3">
          <title>Codeine/Acetaminophen</title>
          <description>Codeine/acetaminophen (30 mg/300 mg)
Codeine/acetaminophen</description>
        </group>
        <group group_id="E4">
          <title>Ibuprofen/Acetaminophen</title>
          <description>Ibuprofen/acetaminophen (400 mg/1000 mg)
Ibuprofen/acetaminophen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Andrew Chang</name_or_title>
      <organization>Albany Medical College</organization>
      <phone>2125555555</phone>
      <email>achang3@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

